Singapore: Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical stu...
Singapore: Isogenica has appointed CTC Laboratory Systems (CTCLS) of Tokyo, Japan, to represent its business in Japan. C...
Singapore: ThermoGenesis, a leading supplier of enabling technologies for the processing, storage and administration of ...
Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...
Singapore: Japan-based Takeda Global Research & Development Centre has received confirmation of the acceptance of su...
Singapore: Thailand hospital is planning to introduce Japanese cancer therapy technology using a heavy ion beam to treat...
Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigati...
Singapore: Genmab has entered into a research collaboration with Japan-based Kyowa Hakko Kirin to create bispecific anti...
Singapore: Japan Science and Technology Agency (JST) and the National Science and Technology Development Agency (NSTDA) ...
Singapore: Daiichi Sankyo has submitted an application for a partial label change in Japan to manufacture and market the...
Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (tenel...
7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...
Singapore: Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent expiri...
Singapore: Takeda Pharmaceutical received an Order for Corrective Action regarding the manufacturing and marketing of Al...
Singapore: Thermo Fisher Scientific signed a long-term license agreement with Fujirebio to make its biomarker assay Pro...
Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's...
Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...
